BenchSci deploys a graph-native ML stack (Cypher, SPARQL, TensorFlow, PyTorch) to power biomedical AI across pharmaceutical and research settings. The tech shape—heavy on graph databases, semantic query languages, and inference frameworks—reflects a core challenge: making sense of unstructured biomedical data at scale. Current hiring skews senior engineering and product roles, with active projects centered on productizing core prediction models, building API/MCP endpoints for scientific data access, and solving hybrid inference and data integration bottlenecks.
Notable leadership hires: Delivery Lead
BenchSci builds an AI platform designed to accelerate biomedical research by automating data interpretation and prediction tasks for scientists. The platform serves pharmaceutical companies and research institutions, with deployment at scale in top-tier organizations. The company operates as a remote-first team headquartered in Toronto, founded in 2015, and is backed by specialized investors including Gradient Ventures (Google's AI fund), F-Prime, Inovia Capital, and TCV. Core product areas include ontology development for drug discovery, predictive modeling for antibody and reagent selection, and programmatic access layers to integrate with existing research workflows.
BenchSci's core stack includes graph databases (Cypher, SPARQL), ML frameworks (TensorFlow, PyTorch), cloud platforms (GCP, AWS, Azure), and infrastructure tools (Kubernetes, Terraform). Data pipelines run on dbt, BigQuery, AlloyDB, and Spanner.
BenchSci has 201–500 employees and is growing, with accelerating hiring velocity focused on senior and mid-level engineers and product roles.
Other companies in the same industry, closest in size